These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26637231)

  • 1. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.
    Karabulut S; Usul Afsar C; Karabulut M; Alis H; Erturk K; Karaman S; Kones O; Bilgin E; Tas F
    J BUON; 2016; 21(4):895-902. PubMed ID: 27685911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.
    Usul Afsar Ç; Karabulut M; Karabulut S; Alis H; Gonenc M; Dagoglu N; Serilmez M; Tas F
    J Infect Chemother; 2017 Apr; 23(4):196-200. PubMed ID: 28087305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer.
    Afsar CU; Karabulut M; Karabulut S; Ozal ST; Cikot M; Serilmez M; Tas F
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30544746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
    Karabulut M; Afsar CU; Serilmez M; Karabulut S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma.
    Karabulut S; Afsar CU; Karabulut M; Alis H; Bozkurt MA; Aydogan F; Serilmez M; Tas F
    BBA Clin; 2016 Dec; 6():138-142. PubMed ID: 27785418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.
    Tas F; Karabulut S; Bilgin E; Sen F; Yildiz I; Tastekin D; Ciftci R; Duranyildiz D
    Tumour Biol; 2013 Dec; 34(6):3529-36. PubMed ID: 23784459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
    Liu P; Zhu Y; Liu L
    Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-17 levels can be diagnostic for gastric cancer.
    Karabulut M; Usul Afsar C; Serimez M; Karabulut S
    J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer.
    Ren C; Chen Y; Han C; Fu D; Chen H
    Tumour Biol; 2014 Nov; 35(11):11467-72. PubMed ID: 25123265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
    Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
    Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic role of serum interleukin-18 in gastric cancer patients.
    Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
    World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
    Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
    J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
    Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
    Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.